Also, the arrow weights from Fig. 6 clearly indicate that in SFV-treated tumour-prone mice there was a more pronounced unbalance in cell differentiation from the multipotent progenitors (MPP) towards common myeloid progenitors (CMP) compared to the PGK treatment. Here, PRKG1 is linked to neoplasm.